Left ventricular thrombus and subsequent thromboembolism, comparison of anticoagulation, surgical removal, and antiplatelet agents

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 1, 2013, Pages 73-93

  Lee, Joo Myung ^a   Park, Jin Joo ^a   Jung, Hee Won ^a   Cho, Young Seok ^b   Oh, Il Young ^b   Yoon, Chang Hwan ^b   Suh, Jung Won ^b   Chun, Eun Ju ^b   Choi, Sang Il ^b   Youn, Tae Jin ^b   Lim, Cheong ^b   Cho, Goo Yeong ^b   Chae, In Ho ^b   Park, Kay Hyun ^b   Choi, Dong Ju ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Acute myocardial infarction; Dilated cardiomyopathy; Intracardiac thrombus; Ischemic cardiomyopathy; Left ventricular thrombus

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIFLUSAL; WARFARIN;

ADULT; BLEEDING; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART VENTRICLE SIZE; HEART VENTRICLE THROMBOSIS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SCORING SYSTEM; SURGICAL INFECTION; SURVIVAL; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANTICOAGULANTS; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL AUDIT; PLATELET AGGREGATION INHIBITORS; THROMBOEMBOLISM; THROMBOSIS;

EID: 84873858031     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13540     Document Type: Review

References (41)

1. Johannessen KA, Nordrehaug JE, von der Lippe G: Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction. Br Heart J, 1984; 51: 553-556
2. Asinger RW, Mikell FL, Elsperger J, Hodges M: Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med, 1981; 305: 297-302
3. de Gregorio C: Cardioembolic outcomes in stress-related cardiomyopathy complicated by ventricular thrombus: asystematic review of 26 clinical studies. Int J Cardiol, 2010; 141: 11-17
4. Sharma ND, McCullough PA, Philbin EF, Weaver WD: Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest, 2000; 117: 314-320
5. Haugland JM, Asinger RW, Mikell FL, Elsperger J, Hodges M: Embolic potential of left ventricular thrombi detectedby two-dimensional echocardiography. Circulation, 1984; 70: 588-598
6. Stratton JR, Resnick AD: Increased embolic risk in patients with left ventricular thrombi. Circulation, 1987; 75: 1004-1011
7. Vaitkus PT, Barnathan ES: Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J Am Coll Cardiol, 1993; 22: 1004-1009
8. Kontny F, Dale J, Abildgaard U, Pedersen TR: Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study. J Am Coll Cardiol, 1997; 30: 962-969
9. van Dantzig JM, Delemarre BJ, Bot H, Visser CA: Left ventricular thrombus in acute myocardial infarction. Eur Heart J, 1996; 17: 1640-1645
10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation, 2004; 110: 588-636
11. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D,Schnittger I, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr, 1989; 2: 358-367
12. Hart RG, Coull BM, Hart D: Early recurrent embolism Marassociated with nonvalvular atrial fibrillation: a retrospective study. Stroke, 1983; 14: 688-693
13. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Gabriel Steg P, Morel Ma, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW: Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation, 2007; 115: 2344-2351
14. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation, 1987; 76: 142-154
15. Gu XS, Rosenbaum PR: Comparison of Multivariate Matching Methods: Structures, Distances, and Algorithms. Journal of Computational and Graphical Statistics, 1993; 2: 405-420
16. Kovacevic-Preradovic T, Jenni R, Oechslin EN, Noll G, Seifert B, Attenhofer Jost CH: Isolated left ventricular noncompaction as a cause for heart failure and heart transplantation: a single center experience. Cardiology, 2009; 112: 158-164
17. Nihoyannopoulos P, Smith GC, Maseri A, Foale RA: The natural history of left ventricular thrombus in myocardialinfarction: a rationale in support of masterly inactivity. J Am Coll Cardiol, 1989; 14: 903-911
18. Weinreich DJ, Burke JF, Pauletto FJ: Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography. Ann Intern Med, 1984; 100: 789-794
19. Visser CA, Kan G, Meltzer RS, Dunning AJ, Roelandt J: Embolic potential of left ventricular thrombus after myocardial infarction: a two-dimensional echocardiographic study of 119 patients. J Am Coll Cardiol, 1985; 5: 1276-1280
20. Keren A, Goldberg S, Gottlieb S, Klein J, Schuger C, Medina A, Tzivoni D, Stern S: Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol, 1990; 15: 790-800
21. Jugdutt BI, Sivaram CA: Prospective two-dimensional echocardiographic evaluation of left ventricular thrombusand embolism after acute myocardial infarction. J Am Coll Cardiol, 1989; 13: 554-564
22. Nili M, Deviri E, Jortner R, Strasberg B, Levy MJ: Surgical removal of a mobile, pedunculated left ventricular thrombus: report of 4 cases. Ann Thorac Surg, 1988; 46: 396-400
23. Duarte IG, Fenton KN, Brown WM, 3rd: Video-assisted removal of left ventricular mass. Ann Thorac Surg, 1997; 63: 833-835
24. Kanemitsu S, Miyake Y, Okabe M: Surgical removal of a left ventricular thrombus associated with cardiac sarcoidosis. Interact Cardiovasc Thorac Surg, 2008; 7: 333-335
25. Minami H, Asada T, Gan K: Surgical removal of left ventricular ball-like thrombus following large transmural acute myocardial infarction using the infarction exclusion technique: David-Komeda procedure. Circ J, 2008; 72 1547-1549
26. Fang MC, Go AS, Chang Y, Hylek EM, Henault LE, Jensvold NG, Singer DE: Death and disability from warfarin-associated intracranial and extracranial hemorrhages.Am J Med, 2007; 120: 700-705
27. Hart RG, Tonarelli SB, Pearce LA: Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke, 2005; 36: 1588-1593
28. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM: The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med, 2004; 164: 880-884
29. Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, Topol EJ, Manoukian SV: Predictors and impact of major hemorrhage on mortality following percutaneouscoronary intervention from the REPLACE-2 Trial. Am J Cardiol, 2007; 100: 1364-1369
30. Hochholzer W, Wiviott SD, Antman EM, Contant CF, Guo J, Giugliano RP, Dalby AJ, Montalescot G, Braunwald E: Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38). Circulation, 2011; 123: 2681-2689
31. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ: An evidence-based causative classification system for acute ischemic stroke. Ann Neurol, 2005; 58: 688-697
32. Ruiz-Bailen M, Aguayo de Hoyos E, Ruiz-Navarro S, Diaz-Castellanos MA, Rucabado-Aguilar L, Gomez-Jimenez FJ, Martinez-Escobar S, Moreno RM, Fierro-Roson J: Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation, 2005; 66: 175-181
33. Doufekias E, Segal AZ, Kizer JR: Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol, 2008; 51: 1049-1059
34. Park KW, Park JJ, Jeon KH, Kang SH, Oh IY, Yang HM, Cho HJ, Lee HY, Kang HJ, Koo BK, Oh BH, Park YB, Kim HS: Clinical predictors of high posttreatment platelet reactivity to clopidogrel in Koreans. Cardiovasc Ther, 2012; 30: 5-11
35. Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS: Predictors of heightened platelet reactivity despite dualantiplatelettherapy in patients undergoing percutaneous coronary intervention. Am J Cardiol, 2009; 103: 1339-1343
36. Scandlyn MJ, Stuart EC, Rosengren RJ: Sex-specific differences in CYP450 isoforms in humans. Expert Opin Drug Metab Toxicol, 2008; 4: 413-424
37. Wienkers LC, Wurden CJ, Storch E, Kunze KL, Rettie AE, Trager WF: Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metab Dispos, 1996; 24: 610-614
38. Turtzo LC, McCullough LD: Sex differences in stroke. Cerebrovasc Dis, 2008; 26: 462-474
39. Vouyouka AG, Kent KC: Arterial vascular disease in women. J Vasc Surg, 2007; 46: 1295-1302
40. Mezzano D, Espana F, Panes O, Medina P, Pais E, Mar shall G, Tagle R, Downey P, Caceres S, Gonzalez F, Quiroga T, Pereira J: Increased activation of protein C, but lower plasma levels of free, activated protein C inuraemic patients: relationship with systemic inflammation and haemostatic activation. Br J Haematol, 2001; 113: 905-910
41. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH: A prospective study of risk factors for pulmonary embolism in women. JAMA, 1997; 277: 642-645